Calendar ABVC BioPharma, Inc.

Equities

ABVC

US00091F3047

Market Closed - Nasdaq 21:00:00 01/05/2024 BST 5-day change 1st Jan Change
1.13 USD -9.60% Intraday chart for ABVC BioPharma, Inc. -23.65% -2.59%

Chart calendar ABVC BioPharma, Inc.

a7.IblK4JjjBPypvFVUtFOmQ97cXuoBNuZurI_6VVtgKEM.Rd4sruGhaKOd1RYs3WTQNZupNpBGXt4jwLapbQgpWzZt3A60rs5tkJmLJg~1772cd58fe5d8f4f4d4411123d2713ca

Upcoming events on ABVC BioPharma, Inc.

12/05/2024 Q1 2024 Earnings Release (Projected)
13/05/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
27/03/2025 Q4 2024 Earnings Release (Projected)

Past events on ABVC BioPharma, Inc.

14/03/2024 13:30 Q4 2023 Earnings Release
16/01/2024 13:00 Annual General Meeting
15/11/2023 14:00 Q3 2023 Earnings Release
31/03/2023 23:49 Q4 2022 Earnings Release
14/11/2022 23:20 Q3 2022 Earnings Release
15/08/2022 22:48 Interim 2022 Earnings Release
20/05/2022 14:00 Annual General Meeting
16/05/2022 22:46 Q1 2022 Earnings Release
31/03/2022 21:18 FY 2021 Earnings Release
29/03/2022 16:00 Maxim Group Virtual Growth Conference - Panel
15/11/2021 21:33 Q3 2021 Earnings Release
12/08/2021 13:27 Interim 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,70


0,48
0,54
-10.14%
0,36
0,59
-39.58%
0,97
0,39
146.06%

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-8,51
-4,96
-71.6%
-11,7
-6,92
-69.11%
-15,1
-17,0
10.89%

0,00

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-10,8
-7,95
-35.94%
-11,2
-6,98
-60.72%
-15,5
-16,9
8.12%

-13,1

Net income
Million USD
Released
Forecast
Spread
-3,64


-9,79
-6,81
-43.85%
-12,8
-5,99
-114.23%
-16,4
-16,5
0.48%

0,00

EPS
USD
Released
Forecast
Spread
-2,10


-5,00
-3,40
-47.06%
-5,10
-2,30
-121.74%
-5,20
-5,20
0%

0,00

Announcement Date15/05/2016/03/2131/03/2231/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales
Million USD
Released
Forecast
Spread
-0,04
0,20
-120.48%



0,31
0,03
1107.02%
0,04
0,03
61.46%
0,59
0,01
4355.3%
0,13
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-6,45
-1,66
-287.62%



-2,05
-3,95
48.24%
-3,72
-6,34
41.43%
-3,13
-4,98
37.11%



Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-5,89
-1,65
-255.95%



-2,03
-3,93
48.38%
-3,77
-6,30
40.11%
-3,54
-4,96
28.65%



Net income
Million USD
Released
Forecast
Spread
-7,93
-1,09
-630.05%
-6,00


-1,86
-3,84
51.61%
-3,70
-6,12
39.42%
-4,86
-4,87
0.05%



EPS
USD
Released
Forecast
Spread
-3,10
-0,40
-675%
-2,00


-0,60
-1,25
52%
-1,10
-2,00
45%
-1,50
-1,50
0%
-0,60
-0,50
-20%
Announcement Date31/03/2216/05/2215/08/2214/11/2231/03/2315/05/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ABVC Stock
  4. Calendar ABVC BioPharma, Inc.